Tapentadol is partially metabolized from the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with drugs that enrich or repress the activity/expression of a number of of such enzymes, in addition to with substrates of such enzymes (due to Competitors for your enzyme); some enzyme mediators/substrates require https://englandl655ctj4.wikibestproducts.com/user